跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
Entity SL-NAD+ 100mg
Approved
STANDARD
Entity SL-NAD+ 100mg
iX Biopharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
a1524a1ec5344bf9
Company
iX Biopharma Pty Ltd
Type
Standard
Approval Details
Approval Id
a1524a1ec5344bf9
Product Name
Entity SL-NAD+ 100mg
Artg Id
459386
Artg Name
Entity SL-NAD+ 100mg
Sponsor
iX Biopharma Pty Ltd
Company Detail Path
/organization/ix-biopharma-pty-ltd
Artg Date
2024-08-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
a1524a1ec5344bf9
Type
Standard
Back to TGA Approvals
Entity SL-NAD+ 100mg - TGA Drug Approval Details